STOP AF FIRST
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose is to provide data demonstrating the safety and effectiveness of the Arctic Front Advance Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal AF, without the requirement that the subjects be drug refractory.
Description
The purpose is to provide data demonstrating the safety and effectiveness of the Arctic Front Advance Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal AF, without the requirement that the subjects be drug refractory.
Participants will be paid for their participation.
FAQ
Participants will be paid for their participation.
Details
| Condition | atrial fibrillation |
|---|---|
| Age | 18years - 80years |
| Clinical Study Identifier | TX8367 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.